Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients
Public ClinicalTrials.gov record NCT00081783. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase II Study of Xcellerated T CellsTM in Patients With Relapsed or Refractory Indolent Non-Hodgkin's Lymphoma (NHL)
Study identification
- NCT ID
- NCT00081783
- Recruitment status
- Not listed
- Study type
- Interventional
- Phase
- Phase 2
- Lead sponsor
- Xcyte Therapies
- Industry
- Enrollment
- 40 participants
Conditions and interventions
Conditions
Interventions
- Xcellerated T Cells Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Feb 29, 2004
- Primary completion
- Not listed
- Completion
- Not listed
- Last update posted
- Jun 23, 2005
Started 2004
United States locations
- U.S. sites
- 18
- U.S. states
- 12
- U.S. cities
- 16
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| California Cancer Care | Greenbrae | California | 94904 | Recruiting |
| University of Southern California | Los Angeles | California | 90033 | Not yet recruiting |
| University of California, San Diego | San Diego | California | 92093 | Recruiting |
| Sharp Memorial Hospital | San Diego | California | 92123 | Recruiting |
| University of California, San Francisco | San Francisco | California | 94143 | Recruiting |
| Rocky Mountain Cancer Centers | Denver | Colorado | 80218 | Recruiting |
| Atlanta Cancer Care | Roswell | Georgia | 30342 | Recruiting |
| Johns Hopkins University | Baltimore | Maryland | 21231 | Recruiting |
| Center for Cancer & Blood Disorders | Bethesda | Maryland | 20817 | Recruiting |
| Dana-Farber Cancer Institute | Boston | Massachusetts | 02115 | Recruiting |
| Washington University | St Louis | Missouri | 63110 | Recruiting |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08903 | Recruiting |
| Ohio State University | Columbus | Ohio | 43210 | Recruiting |
| Oregon Health Sciences University | Portland | Oregon | 97239 | Recruiting |
| Cancer Centers of the Carolinas | Greenville | South Carolina | 29605 | Recruiting |
| MD Anderson Cancer Center | Houston | Texas | 77030 | Recruiting |
| Swedish Cancer Institute | Seattle | Washington | 98104 | Recruiting |
| Virginia Mason | Seattle | Washington | 98111 | Recruiting |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00081783, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 23, 2005 · Synced Jul 24, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00081783 live on ClinicalTrials.gov.